Luana Guimaraes Sousa

13PUBLICATIONS
36CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersSolid tumoursOncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Apr 13, 2026
Axitinib plus Avelumab in Recurrent/Metastatic Adenoid Cystic Carcinoma: Biomarker Analysis and Updated Results of the Phase II Trial.

Camilla O Hoff, Simon Heeke, Yoshitsugu Mitani

|Feb 19, 2026
Sustained Response to Lorlatinib and Pemetrexed in ALK Fusion-Positive Anaplastic Thyroid Carcinoma With Multiple Distant Metastases: A Case Report.

Matheus Sewastjanow-Silva, Maria E Cabanillas, Eduardo Andreazza Dal Lago

|Mar 03, 2025
Clinical Outcomes With Notch Inhibitors in Notch-Activated Recurrent/Metastatic Adenoid Cystic Carcinoma.

Camilla O Hoff, Luana G de Sousa, Flavia Bonini

|Apr 05, 2024
First Use of AXL Targeting in Metastatic, Refractory, Adenoid Cystic Carcinoma: A Case Report.

Camilla O Hoff, Eduardo Andreazza Dal Lago, Juliana Mota Siqueira

|May 31, 2023
Spatial Immunoprofiling of Adenoid Cystic Carcinoma Reveals B7-H4 Is a Therapeutic Target for Aggressive Tumors.

Luana Guimaraes Sousa, Daniel J McGrail, Felippe Lazar Neto

Pageof 3